<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>大叔快评 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-22T20:37:03+08:00</updated>
  <subtitle>肿瘤学临床研究及制药企业研发评述</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>武田:新一代ALK抑制剂ALUNBRIG日本获批</title>
    <updated>2021-01-22T18:53:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/FwHCh4cppM14wmDes06euQ</id>
    <link href="https://mp.weixin.qq.com/s/FwHCh4cppM14wmDes06euQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田中国总裁单国洪先生当选“2020年度十大医药产业人物”</title>
    <updated>2021-01-21T22:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/EbIIRa-fKuyOxYUkyxuSxQ</id>
    <link href="https://mp.weixin.qq.com/s/EbIIRa-fKuyOxYUkyxuSxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2714】COMMF市场及销售分论坛｜圆桌讨论精要（一）</title>
    <updated>2021-01-21T22:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/fkBQ89Lr_AQf2FUM1O_pkw</id>
    <link href="https://mp.weixin.qq.com/s/fkBQ89Lr_AQf2FUM1O_pkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>胡豫教授：后疫情时代多发性骨髓瘤的临床管理和实践启示</title>
    <updated>2021-01-21T22:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/FADPcjOf4S1zG6tDGvQBiw</id>
    <link href="https://mp.weixin.qq.com/s/FADPcjOf4S1zG6tDGvQBiw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>A+学院 | 胡群教授：抑制物管理国内外最新进展</title>
    <updated>2021-01-21T22:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/pk9Bd8PFYw3TS3jOrHYNYQ</id>
    <link href="https://mp.weixin.qq.com/s/pk9Bd8PFYw3TS3jOrHYNYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田中国：新一代ARB降压药物中国获批</title>
    <updated>2021-01-20T23:36:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/DWlxA7z8G3E86KEDKJasiA</id>
    <link href="https://mp.weixin.qq.com/s/DWlxA7z8G3E86KEDKJasiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2708】领袖汇聚丨中国肿瘤医药营销趋势论坛于今日圆满落幕！</title>
    <updated>2021-01-20T23:36:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/se-JDg1L4jQ7QghoTGBvvQ</id>
    <link href="https://mp.weixin.qq.com/s/se-JDg1L4jQ7QghoTGBvvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田中国与镁信健康达成战略合作</title>
    <updated>2021-01-20T23:36:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/nK5qqE-3qrb0e2skHVN_Dg</id>
    <link href="https://mp.weixin.qq.com/s/nK5qqE-3qrb0e2skHVN_Dg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MM课堂 | 姜华教授：多发性骨髓瘤（MM）治疗时机探讨</title>
    <updated>2021-01-20T23:36:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/FvY6Mo8Thc-kYMyKHea7Kg</id>
    <link href="https://mp.weixin.qq.com/s/FvY6Mo8Thc-kYMyKHea7Kg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人物专访丨武田副总裁陈杰博士：洞见悬而未决的中国特色临床痛点</title>
    <updated>2021-01-20T23:36:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/kXSjqd_YBav2Bk6zV5LhuQ</id>
    <link href="https://mp.weixin.qq.com/s/kXSjqd_YBav2Bk6zV5LhuQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>COMMF医学分论坛圆桌丨Medical Affairs眼中的医药营销趋势</title>
    <updated>2021-01-19T15:55:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/wd8ESZEi0A3qUN2oe0dvsQ</id>
    <link href="https://mp.weixin.qq.com/s/wd8ESZEi0A3qUN2oe0dvsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>WCLC20 前瞻丨来看看免疫治疗更多的长期生存数据</title>
    <updated>2021-01-19T15:55:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/cGnkr2OEVOnRuwQ81lwhCw</id>
    <link href="https://mp.weixin.qq.com/s/cGnkr2OEVOnRuwQ81lwhCw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>接受分子靶向药物以及免疫检查点抑制剂治疗患者药物相关性肺炎的胸部CT诊断和临床管理</title>
    <updated>2021-01-19T15:55:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/GsRJglWcoGLD15VgVIFDTg</id>
    <link href="https://mp.weixin.qq.com/s/GsRJglWcoGLD15VgVIFDTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再谈医学驱动，带给我们哪些启示？</title>
    <updated>2021-01-18T18:52:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/OWg7GFaQA0t7wjW9wdYI6Q</id>
    <link href="https://mp.weixin.qq.com/s/OWg7GFaQA0t7wjW9wdYI6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿胀的假象与隐匿的真相</title>
    <updated>2021-01-18T18:52:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/CIzYFZRPdL4Bb6DUk0rWxA</id>
    <link href="https://mp.weixin.qq.com/s/CIzYFZRPdL4Bb6DUk0rWxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Ⅱ期临床试验：维布妥昔单抗治疗不同CD30表达水平复发难治DLBCL</title>
    <updated>2021-01-18T18:52:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/NRa7atW7N78X0CCD4rt8qQ</id>
    <link href="https://mp.weixin.qq.com/s/NRa7atW7N78X0CCD4rt8qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二届武田中国血液肿瘤卓越实践论坛成功举行</title>
    <updated>2021-01-17T20:54:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/O3DgTTy_YZCrELwMuG4EfA</id>
    <link href="https://mp.weixin.qq.com/s/O3DgTTy_YZCrELwMuG4EfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“新新”向荣，“血”术有成——盘点2020年血液领域FDA批准的新药</title>
    <updated>2021-01-17T20:54:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/f2oN4dCQArbvFDXuyY2ssA</id>
    <link href="https://mp.weixin.qq.com/s/f2oN4dCQArbvFDXuyY2ssA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NEJM:腺病毒载体新冠肺炎疫苗phase I-IIa结果</title>
    <updated>2021-01-16T20:33:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/K1Wp6kMCo6ItA4bbP9UVVQ</id>
    <link href="https://mp.weixin.qq.com/s/K1Wp6kMCo6ItA4bbP9UVVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>隐秘的真相之疼痛的假象</title>
    <updated>2021-01-15T21:51:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/QuVcNNa8BqVhBouphRuKSA</id>
    <link href="https://mp.weixin.qq.com/s/QuVcNNa8BqVhBouphRuKSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>